Miura K - Search Results

1

Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5.

Wang LT, Cooper AJR, Farrell B, Miura K, Diouf A, Müller-Sienerth N, Crosnier C, Purser L, Kirtley PJ, Maciuszek M, Barrett JR, McHugh K, Ogwang R, Tucker C, Li S, Doumbo S, Doumtabe D, Pyo CW, Skinner J, Nielsen CM, Silk SE, Kayentao K, Ongoiba A, Zhao M, Nguyen DC, Lee FE, Minassian AM, Geraghty DE, Traore B, Seder RA, Wilder BK, Crompton PD, Wright GJ, Long CA, Draper SJ, Higgins MK, Tan J. Wang LT, et al. Among authors: miura k. Cell. 2024 Sep 5;187(18):4981-4995.e14. doi: 10.1016/j.cell.2024.06.037. Epub 2024 Jul 25. Cell. 2024. PMID: 39059381 Free PMC article.

2

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.

Malkin EM, Durbin AP, Diemert DJ, Sattabongkot J, Wu Y, Miura K, Long CA, Lambert L, Miles AP, Wang J, Stowers A, Miller LH, Saul A. Malkin EM, et al. Among authors: miura k. Vaccine. 2005 May 2;23(24):3131-8. doi: 10.1016/j.vaccine.2004.12.019. Vaccine. 2005. PMID: 15837212 Free PMC article. Clinical Trial.

3

posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.

Giersing B, Miura K, Shimp R, Wang J, Zhou H, Orcutt A, Stowers A, Saul A, Miller LH, Long C, Singh S. Giersing B, et al. Among authors: miura k. Infect Immun. 2005 Jul;73(7):3963-70. doi: 10.1128/IAI.73.7.3963-3970.2005. Infect Immun. 2005. PMID: 15972483 Free PMC article.

4

Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.

Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA. Singh S, et al. Among authors: miura k. Infect Immun. 2006 Aug;74(8):4573-80. doi: 10.1128/IAI.01679-05. Infect Immun. 2006. PMID: 16861644 Free PMC article.

5

Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.

Miura K, Keister DB, Muratova OV, Sattabongkot J, Long CA, Saul A. Miura K, et al. Malar J. 2007 Aug 8;6:107. doi: 10.1186/1475-2875-6-107. Malar J. 2007. PMID: 17686163 Free PMC article.

6

In immunization with Plasmodium falciparum apical membrane antigen 1, the specificity of antibodies depends on the species immunized.

Miura K, Zhou H, Muratova OV, Orcutt AC, Giersing B, Miller LH, Long CA. Miura K, et al. Infect Immun. 2007 Dec;75(12):5827-36. doi: 10.1128/IAI.00593-07. Epub 2007 Oct 8. Infect Immun. 2007. PMID: 17923516 Free PMC article.

7

Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines.

Miura K, Orcutt AC, Muratova OV, Miller LH, Saul A, Long CA. Miura K, et al. Vaccine. 2008 Jan 10;26(2):193-200. doi: 10.1016/j.vaccine.2007.10.064. Epub 2007 Nov 20. Vaccine. 2008. PMID: 18054414 Free PMC article.

8

Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine design.

Duan J, Mu J, Thera MA, Joy D, Kosakovsky Pond SL, Diemert D, Long C, Zhou H, Miura K, Ouattara A, Dolo A, Doumbo O, Su XZ, Miller L. Duan J, et al. Among authors: miura k. Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7857-62. doi: 10.1073/pnas.0802328105. Epub 2008 May 30. Proc Natl Acad Sci U S A. 2008. PMID: 18515425 Free PMC article.

9

Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria.

Mullen GE, Ellis RD, Miura K, Malkin E, Nolan C, Hay M, Fay MP, Saul A, Zhu D, Rausch K, Moretz S, Zhou H, Long CA, Miller LH, Treanor J. Mullen GE, et al. Among authors: miura k. PLoS One. 2008 Aug 13;3(8):e2940. doi: 10.1371/journal.pone.0002940. PLoS One. 2008. PMID: 18698359 Free PMC article. Clinical Trial.

10

Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination.

Miura K, Zhou H, Moretz SE, Diouf A, Thera MA, Dolo A, Doumbo O, Malkin E, Diemert D, Miller LH, Mullen GE, Long CA. Miura K, et al. J Immunol. 2008 Dec 15;181(12):8776-83. doi: 10.4049/jimmunol.181.12.8776. J Immunol. 2008. PMID: 19050299 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,756 results

Search Page

Filters